REGISTERED NUMBER: 06757413 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 November 2025

for

Polyclinic Services Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

S Patel

REGISTERED OFFICE:

39 Bromley Road

Catford

London

SE6 2TS

REGISTERED NUMBER:

06757413 (England and Wales)

ACCOUNTANTS:

Kallis LLP

Chartered Certified Accountant

22 Westward Way

Harrow

Middlesex

HA3 0SE

FIXED ASSETS

Intangible assets

4

-

-

Tangible assets

5

311,555

327,558

Investment property

6

419,500

419,500

731,055

747,058

CURRENT ASSETS

Stocks

177,809

129,441

Debtors

7

4,087,880

2,184,121

Cash at bank and in hand

15,570

1,570,242

4,281,259

3,883,804

CREDITORS

Amounts falling due within one year

8

318,870

304,457

NET CURRENT ASSETS

3,962,389

3,579,347

TOTAL ASSETS LESS CURRENT LIABILITIES

4,693,444

4,326,405

CREDITORS

Amounts falling due after more than one year

9

542,779

542,779

NET ASSETS

4,150,665

3,783,626

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

4,150,565

3,783,526

SHAREHOLDERS' FUNDS

4,150,665

3,783,626

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 August 2026 and were signed by:

S Patel - Director

1.	STATUTORY INFORMATION

Polyclinic Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Purchased goodwill is initially recognised at cost. After recognition purchased goodwill is amortised over its expected useful life and measured at cost less accumulated amortisation.

Goodwill is considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceeds 10 years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Leasehold Improvement

-

2% on cost

Fixtures and fittings

-

25% on reducing balance

Motor vehicles

-

25% on reducing balance

Computer equipment

-

25% on reducing balance

Investment property

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially

recognised at cost, which includes the purchase cost and any directly attributable expenditure.

Subsequently it is measured at fair value at the reporting end date. The surplus or deficit on revaluation is recognised in the profit and loss account.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2024 - 18 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 December 2024

and 30 November 2025

300,000

AMORTISATION

At 1 December 2024

and 30 November 2025

300,000

NET BOOK VALUE

At 30 November 2025

-

At 30 November 2024

-

5.	TANGIBLE FIXED ASSETS

Fixtures

Leasehold

and

Motor

Computer

Improvement

fittings

vehicles

equipment

Totals

£

£

£

£

£

COST

At 1 December 2024

402,505

70,489

87,495

21,094

581,583

Additions

-

475

-

5,512

5,987

At 30 November 2025

402,505

70,964

87,495

26,606

587,570

DEPRECIATION

At 1 December 2024

124,715

62,198

50,584

16,528

254,025

Charge for year

8,050

2,192

9,228

2,520

21,990

At 30 November 2025

132,765

64,390

59,812

19,048

276,015

NET BOOK VALUE

At 30 November 2025

269,740

6,574

27,683

7,558

311,555

At 30 November 2024

277,790

8,291

36,911

4,566

327,558

6.	INVESTMENT PROPERTY

Total

£

FAIR VALUE

At 1 December 2024

and 30 November 2025

419,500

NET BOOK VALUE

At 30 November 2025

419,500

At 30 November 2024

419,500

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Trade debtors

210,325

187,927

Other debtors

3,825,000

1,973,000

VAT

49,441

20,384

Prepayments

3,114

2,810

4,087,880

2,184,121

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Trade creditors

165,788

160,361

Tax

127,014

105,963

Directors Loan account

2,985

7,854

Accrued expenses

23,083

30,279

318,870

304,457

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

30.11.25

30.11.24

£

£

Other loans more 5yrs non-inst

542,779

542,779

Amounts falling due in more than five years:

Repayable otherwise than by instalments

Other loans more 5yrs non-inst

542,779

542,779

10.	RELATED PARTY DISCLOSURES

The company has taken advantage of the exemption available to group undertakings under FRS 102 Section 1A "Small Entities" by not disclosing transaction with wholly owned entities of the Polyclinic Holdings (2024) Limited.

Included within other debtors is an amount due from the following related parties:

Due from PBS Enterprise Limited £328,000 (2024: £328,000 ) a company in which Mr Sanjay Patel is a shareholder.

Due from Healthcare Limited £185,000 (2024: £185,000 ) a company in which Mr Sanjay Patel is a director .

Due from Saxmundham Pharma Limited £60,000 (2024: £60,000 ) a company in which Mr Sanjay Patel is a shareholder.

All the above loans have no terms of repayments or interest attached to them.

11.	ULTIMATE CONTROLLING PARTY

The company is a wholly owned subsidiary of Polyclinic Holdings (2024) Limited, a company registered in England and Wales. The ultimate controlling party of Polyclinic Holdings (2024) Limited is Mr Sanjay Patel.